ConductScience.org, home

Paper37056757

The transdermal cream of Formestane anti-breast cancer by controlling PI3K-Akt pathway and the tumor immune microenvironment.

Gao L and 9 others. Front Immunol, 2023. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. The transdermal cream of Formestane anti-breast cancer by controlling PI3K-Akt pathway and the tumor immune microenvironment. Papers, record 37056757. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37056757

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The transdermal cream of Formestane anti-breast cancer by controlling PI3K-Akt pathway and the tumor immune microenvironment.
PubMed
Journal
Front Immunol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.22
iCite
Revised in PubMed
2026-01-27
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gao LLanyang
2Zhu LLei
3Shen CChen
4Hou XXiaoming
5Chen YYouyou
6Zou LLinglin
7Qiang HHuiyan
8Teichmann ATAlexander T
9Fu WWenguang
10Luo YYao

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Proto-Oncogene Proteins c-aktMajor topic
Mammary Neoplasms, AnimalMajor topic
Rats
Animals
Phosphatidylinositol 3-Kinases
CD8-Positive T-Lymphocytes
Tumor Microenvironment
Androstenedione

Source PubMed

Download CSV of topics

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123982470BTG1 inhibits breast cancer cell growth through induction of cell cycle arrest and apoptosis.Oncol Rep2013https://conductscience.org/library/papers/23982470PubMed
226206099Synergy of molecular targeted approaches and immunotherapy in melanoma: preclinical basis and clinical perspectives.Expert Opin Biol Ther2015https://conductscience.org/library/papers/26206099PubMed
316723503
LRRC4, a putative tumor suppressor gene, requires a functional leucine-rich repeat cassette domain to inhibit proliferation of glioma cells in vitro by modulating the extracellular signal-regulated kinase/protein kinase B/nuclear factor-kappaB pathway.
Mol Biol Cell2006https://conductscience.org/library/papers/16723503PubMed
431942075B cells and tertiary lymphoid structures promote immunotherapy response.Nature2020https://conductscience.org/library/papers/31942075PubMed
520535542Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancer.Breast Cancer Res Treat2010https://conductscience.org/library/papers/20535542PubMed
69690562Antiproliferative gene BTG1 is highly expressed in apoptotic cells in macrophage-rich areas of advanced lesions in Watanabe heritable hyperlipidemic rabbit and human.Lab Invest1998https://conductscience.org/library/papers/9690562PubMed
761502774-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer.Lancet1984https://conductscience.org/library/papers/6150277PubMed
831235695The beneficial androgenic action of steroidal aromatase inactivators in estrogen-dependent breast cancer after failure of nonsteroidal drugs.Cell Death Dis2019https://conductscience.org/library/papers/31235695PubMed
911822752Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): is a clinical benefit still achievable?Ann Oncol2001https://conductscience.org/library/papers/11822752PubMed
1028103936Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells.Breast Cancer Res2017https://conductscience.org/library/papers/28103936PubMed
1112943750Is there a benefit by the sequence anastrozole-formestane for postmenopausal metastatic breast cancer women?J Steroid Biochem Mol Biol2003https://conductscience.org/library/papers/12943750PubMed
1231406251Dynamic interactions between the extracellular matrix and estrogen activity in progression of ER+ breast cancer.Oncogene2019https://conductscience.org/library/papers/31406251PubMed
1325526788Function and mechanism of tumor suppressor gene LRRC4/NGL-2.Mol Cancer2014https://conductscience.org/library/papers/25526788PubMed
1423529824Everolimus in combination with exemestane: a review of its use in the treatment of patients with postmenopausal hormone receptor-positive, HER2-negative advanced breast cancer.Drugs2013https://conductscience.org/library/papers/23529824PubMed
1531942077B cells are associated with survival and immunotherapy response in sarcoma.Nature2020https://conductscience.org/library/papers/31942077PubMed
1633846305Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling.Nat Commun2021https://conductscience.org/library/papers/33846305PubMed
17109701Aromatase inhibitors--IV. Regression of hormone-dependent, mammary tumors in the rat with 4-acetoxy-4-androstene-3,17-dione.J Steroid Biochem1979https://conductscience.org/library/papers/109701PubMed
187850806Overexpression of DAN gene product in normal rat fibroblasts causes a retardation of the entry into the S phase.Cancer Res1995https://conductscience.org/library/papers/7850806PubMed
1929968419Selective Inhibition of Lysine-Specific Demethylase 5A (KDM5A) Using a Rhodium(III) Complex for Triple-Negative Breast Cancer Therapy.Angew Chem Int Ed Engl2018https://conductscience.org/library/papers/29968419PubMed
2028719035Melatonin inhibits nucleus pulposus (NP) cell proliferation and extracellular matrix (ECM) remodeling via the melatonin membrane receptors mediated PI3K-Akt pathway.J Pineal Res2017https://conductscience.org/library/papers/28719035PubMed

See all 38 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42219404Transdermal drug delivery systems in cancer therapy: advances, challenges, and future perspectives.Eur J Clin Pharmacol2026https://conductscience.org/library/papers/42219404PubMed
39676967Novel Glycyrrhetin Ureas Possessing 2-Hydroxy-3-enone A Ring: Modification, Anti-inflammatory Activity, and Targeted STING for the Remedy of Acute Kidney Injury.ACS Omega2024https://conductscience.org/library/papers/39676967PubMed
39343994Nanoemulsion-based transdermal delivery of third-generation steroidal and non-steroidal aromatase inhibitors in preclinical models.Cell Prolif2025https://conductscience.org/library/papers/39343994PubMed
38765245Distinct mechanisms of iron and zinc metal ions on osteo-immunomodulation of silicocarnotite bioceramics.Mater Today Bio2024https://conductscience.org/library/papers/38765245PubMed

Download CSV of cited by

Genes27

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
BTG1694PubTator's text mininghttps://conductscience.org/library/genes/694NCBI Gene
CCNB1891PubTator's text mininghttps://conductscience.org/library/genes/891NCBI Gene
CCND1595PubTator's text mininghttps://conductscience.org/library/genes/595NCBI Gene
CCNE1898PubTator's text mininghttps://conductscience.org/library/genes/898NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CDK1983PubTator's text mininghttps://conductscience.org/library/genes/983NCBI Gene
COL1A11277PubTator's text mininghttps://conductscience.org/library/genes/1277NCBI Gene
CYP19A11588PubTator's text mininghttps://conductscience.org/library/genes/1588NCBI Gene
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
FCGR3A2214PubTator's text mininghttps://conductscience.org/library/genes/2214NCBI Gene
FN12335PubTator's text mininghttps://conductscience.org/library/genes/2335NCBI Gene
IL43565PubTator's text mininghttps://conductscience.org/library/genes/3565NCBI Gene
ITGA53678PubTator's text mininghttps://conductscience.org/library/genes/3678NCBI Gene
KLRB13820PubTator's text mininghttps://conductscience.org/library/genes/3820NCBI Gene
LRRC464101PubTator's text mininghttps://conductscience.org/library/genes/64101NCBI Gene
NCAM14684PubTator's text mininghttps://conductscience.org/library/genes/4684NCBI Gene
PIK3CD5293PubTator's text mininghttps://conductscience.org/library/genes/5293NCBI Gene

See all 27 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37056757

GET https://conductscience.org/api/papers/v1/37056757/references?page=2